- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.09. | ScandiDos AB: Olof Stranding appointed Interim CEO of ScandiDos | 189 | GlobeNewswire (Europe) | ScandiDos AB announces that Olof Stranding has been appointed Interim CEO of ScandiDos, effective 21 September 2026.
Olof Stranding is based in Uppsala and brings extensive experience from senior leadership... ► Artikel lesen | |
| 17.09. | ScandiDos AB Q1 Loss Climbs | 1 | RTTNews | ||
| 22.06. | Listing of subscription rights and paid subscription shares of ScandiDos AB | 305 | GlobeNewswire | With effect from June 23, 2026, the subscription rights in ScandiDos AB will be traded on First North Growth Market. Trading will continue up until and including July 06, 2026.
Instrument:
Subscription... ► Artikel lesen | |
| SCANDIDOS Aktie jetzt für 0€ handeln | |||||
| 17.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.06.2026 | 551 | Xetra Newsboard | Das Instrument EA20 NO0013601245 EAM SOLAR AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 17.06.2026 und ex Kapitalmassnahme am 18.06.2026 The instrument EA20 NO0013601245 EAM SOLAR AS NK... ► Artikel lesen | |
| 06.05. | ScandiDos AB: Anders Murman appointed Acting CEO of ScandiDos | 544 | GlobeNewswire (Europe) | ScandiDos AB announces that Gustaf Piehl is stepping down as Chief Executive Officer at his own request. The Board has appointed Anders Murman as Acting CEO, effective 6 May 2026. A process to recruit... ► Artikel lesen | |
| 13.02. | The observation status for ScandiDos AB is removed | 380 | GlobeNewswire | On November 14, 2025, the shares in ScandiDos AB (the "Company") were given observation status with reference to a mandatory public offer from Spore Invest AB to the other shareholders of the Company.
On... ► Artikel lesen | |
| 14.11.25 | ScandiDos AB receives observation status | 414 | GlobeNewswire | Today, November 14, 2025, Spore Invest AB disclosed a mandatory public offer to the other shareholders in ScandiDos AB.
The rules of Nasdaq First North Growth Market state that an issuer may... ► Artikel lesen |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS | 42,485 | +2,15 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,610 | +2,42 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius Medical Care (FMC) nach der Ankündigung eines Wechsels an der Unternehmensspitze auf "Underweight" mit einem Kursziel... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,820 | +1,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers vor Zahlen zum vierten Geschäftsquartal auf "Hold" mit einem Kursziel von 39 Euro belassen. Er rechne... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning |
SCANDIDOS AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,023 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDIDOS AB finden Sie auf Wallstreet Online.